ACM
ITCI

Aquatic Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Aquatic Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,206
Closed -$435K – 1694
2024
Q4 		$435K Buy
+5,206
New +$428K 0.01% 748
2024
Q2 		– Sell
-300
Closed -$20.8K – 1658
2024
Q1 		$20.8K Sell
300
-5,000
-94% -$344K ﹤0.01% 1095
2023
Q4 		$380K Sell
5,300
-16,900
-76% -$972K 0.01% 699
2023
Q3 		$1.16M Buy
22,200
+7,600
+52% +$443K 0.05% 311
2023
Q2 		$924K Buy
14,600
+2,300
+19% +$143K 0.05% 325
2023
Q1 		$666K Buy
+12,300
New +$595K 0.04% 350
2022
Q2 		– Sell
-1,200
Closed -$73K – 1637
2022
Q1 		$73K Sell
1,200
-2,900
-71% -$151K 0.11% 212
2021
Q4 		$215K Buy
+4,100
New +$172K 0.42% 31

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Aquatic Capital Management's ITCI Position: Q1 2025 in Review

Aquatic Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 5,206 shares — an estimated $435K sold.

Aquatic Capital Management first reported a position in ITCI in Q4 2021 and held it in 8 quarters. The position peaked at $1.16M in Q3 2023. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Aquatic Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 5,206 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $435K.
  • Aquatic Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q4 2021 and held it in 8 quarters.
  • Aquatic Capital Management's Intra-Cellular Therapies Inc. position peaked at $1.16M in Q3 2023.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.